Dataset of mitochondrial genome variants in oncocytic tumors

Area of Science:

• Genomics
• Oncology
• Mitochondrial Biology

Background:

• Oncocytic tumors are neoplasms characterized by cells rich in mitochondria.
• Mitochondrial dysfunction is increasingly implicated in tumorigenesis.
• Understanding mitochondrial DNA (mtDNA) alterations in oncocytic tumors is crucial for elucidating their pathogenesis.

Purpose of the Study:

• To identify and characterize mitochondrial genome variants in oncocytic tumors.
• To assess the potential pathogenicity of novel mtDNA variants.
• To provide a dataset of mtDNA variants associated with oncocytic tumors.

Main Methods:

• Whole mitochondrial genome sequencing using Sanger sequencing technology.
• Comparison of tumor mtDNA sequences against the revised Cambridge reference sequence.
• Exclusion of population-specific haplogroup-defining variants.
• In silico pathogenicity prediction of novel missense variants using the Mitimpact 2 program.

Main Results:

• A dataset of mitochondrial genome variants specific to oncocytic tumors was generated.
• Novel missense variants within the mitochondrial genome of oncocytic tumors were identified.
• Pathogenic predictions were performed for these novel variants, offering insights into their functional impact.

Conclusions:

• The study provides a comprehensive dataset of mitochondrial genome variants in oncocytic tumors.
• Identified variants may contribute to the development or progression of oncocytic tumors.
• Further functional studies are warranted to confirm the pathogenicity and role of these mtDNA variants in oncocytic tumorigenesis.